Clinical Trials Logo

Clinical Trial Summary

Embryo adhesion and placentation depend on tissue plasminogen activator (tPA)-mediated activation of brain-derived neurotrophic factor, vascular endothelial growth factor and other growth factors, formation of hemidesmosomes, and degradation of extracellular matrix and basement membrane, either directly or by activating matrix metalloproteinases.

Since glucose and insulin stimulate release of a major tPA inhibitor by endothelial cells - plasminogen activator inhibitor (PAI)-1 - the investigators hypothesized that lifestyle interventions proven effective in maintaining glucose and insulin levels within the normal range would increase the take home baby rate in women undergoing assisted reproduction.


Clinical Trial Description

Tissue plasminogen activator (tPA) has a well-known role in the coagulation pathway. tPA converts plasminogen to plasmin. Plasmin dissolves fibrin clots, thus limiting thrombus formation to the site of vascular injury.

In the extravascular compartment, tPA is a pivotal mediator of tissue formation and remodeling. Due to its proteolytic activity, tPA participates in processes as diverse as embryo adhesion, placental angiogenesis and vasculogenesis, and neuronal plasticity. Embryo adhesion and placentation, for example, depend on tPA-mediated activation of brain-derived neurotrophic factor, vascular endothelial growth factor and other growth factors, formation of hemidesmosomes, and degradation of extracellular matrix and basement membrane, either directly or by activating matrix metalloproteinases.

Assuming low tPA activity would impair both blood clot dissolution and placentation, the investigators postulated that patients with consecutive first-trimester abortions would have a high prevalence of severe dysmenorrhea, accompanied by the passage of large clots.

In 2011, the investigators assessed the prevalence of severe dysmenorrhea during early adolescence in two groups. The first one was made of women with ≥ 2 consecutive first-trimester abortions, and the other, of women with ≥ 2 living births, and no losses or preterm deliveries. Severe dysmenorrhea was defined as suprapubic menstrual cramp, intense enough to cause repeated absenteeism from school or fainting in the absence of analgesia. Early adolescents are unlikely to use contraceptives, or to have become pregnant, two situations that may reduce the pain. In this study, severe dysmenorrhea increased the chances of having consecutive first-trimester miscarriages by sevenfold (95% Confidence Interval: 3.4 to 14.1; p<0.001).

Since glucose and insulin stimulate release of a major tPA inhibitor by endothelial cells - plasminogen activator inhibitor (PAI)-1 - the investigators hypothesized that lifestyle interventions proven effective in maintaining glucose and insulin levels within the normal range would increase the take home baby rate in women undergoing assisted reproduction.

The protocol has already been tested at a Brazilian tertiary care center in women with unexplained consecutive first-trimester abortions, conceiving spontaneously. The objective of this study was to observe the impact of lifestyle interventions on the take home baby rate, and to observe if the intervention could reduce the prevalence of preeclampsia and neonatal hypoglycemia.

From 2011 to 2015, 480 patients aged 18 to 42 years with ≥ 2 consecutive first-trimester abortions documented by pathology or ultrasonography, were randomly assigned to protocol Walking and Diet (W+D) or to standard follow-up (controls). Women were enrolled independent of having had severe dysmenorrhea during adolescence. Patients assigned to protocol W+D were instructed to walk briskly for ≥ 40 minutes seven days a week. In addition, they were recommended to avoid high-carbohydrate meals such as snacks, candies, fiber-free juices, coconut water and sugar-sweetened beverages, and to eat two daily servings of meat, poultry, fish (e.g. 2 g/kg) or other protein-rich food, starting when they decided to get pregnant and continuing until delivery. Women with antiphospholipid antibodies, second- or third-trimester losses, multiple pregnancies, anatomical abnormalities that could increase the risk of first-trimester abortions, or any condition requiring a priori anticoagulation were excluded. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02648555
Study type Interventional
Source Hospital dos Servidores do Estado do Rio de Janeiro
Contact Silvia Hoirisch-Clapauch, MD, PhD
Phone +55-21-999737500
Email sclapauch@ig.com.br
Status Not yet recruiting
Phase N/A
Start date May 2016
Completion date May 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02843269 - Multiple-component Workplace FRamed Intervention to Decrease Occupational Muscle Pain - FRIDOM N/A
Completed NCT01958307 - Healthy Living in Pregnancy N/A
Completed NCT06072742 - Effect of Lifestyle on Caries and Apical Periodontitis
Terminated NCT05084274 - Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program N/A
Not yet recruiting NCT06375460 - Real-time Engagement for Learning to Effectively Control Type 2 Diabetes N/A
Enrolling by invitation NCT04314882 - The Danish National Survey of Diet and Physical Activity 2021-2023
Completed NCT02736214 - Reproductive Life Plan-based Counseling With Men N/A
Recruiting NCT03711539 - Lifetime Endurance Exercise to Prevent Coronary Artery Disease
Completed NCT05264155 - Evaluation of the Impact of Adaptive Goal Setting on Engagement Levels of Government Staff With a Gamified mHealth Tool N/A
Recruiting NCT03242174 - Health Behaviors in Pregnancy
Recruiting NCT06248775 - Nursing Prehabilitation Intervention Supported With Technology for Vascular Surgery in People With Type 2 Diabetes N/A
Recruiting NCT04610983 - Omega-3 Bioavailability From Vegetable-omega-3 Enriched Products Phase 2
Completed NCT05355038 - Effect of Lifestyle Modification on Pregnancy Outcome for GDM N/A
Not yet recruiting NCT05600205 - Evaluation of Combined Support for the Ambulatory Lifestyle Intervention N/A
Active, not recruiting NCT03045237 - Healthy Bellies - Intervention Program During Pregnancy on Women and Newborn N/A
Completed NCT03396029 - Tailored Written Lifestyle Feedback in Colorectal Cancer Screening N/A
Active, not recruiting NCT06226948 - Using the Visualization for Lifestyle Change in Patients at Risk of Cardiovascular Diseases N/A
Recruiting NCT04411511 - COVID-19, Obesity and Lifestyle in Children
Recruiting NCT05533749 - Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Patients With Severe Mental Illness N/A
Completed NCT02786394 - Return to Everyday Activities in the Community and Home N/A